SCHEMBL6405008

SCHEMBL6405008

Cc1cc(Cl)ccc1NC(=O)Nc1cccc(C2=NNC(=O)CC2(C)C)c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 1/20 0.45
CNR1 P21554 9/20 0.43
AURKB Q96GD4 2/20 0.43
MET P08581 1/20 0.43
PDGFRB P09619 1/20 0.43
CDK8 P49336 1/20 0.43
ROCK1 Q13464 1/20 0.43
NTRK3 Q16288 1/20 0.43
NTRK2 Q16620 1/20 0.43
CLK4 Q9HAZ1 1/20 0.43
GRIK1 P39086 1/20 0.43
MAPT P10636 1/20 0.42
PKM P14618 1/20 0.42
HTT P42858 1/20 0.42
GRM5 P41594 1/20 0.41
KDR P35968 2/20 0.41
IDH1 O75874 1/20 0.41
ROCK2 O75116 1/20 0.41
RET P07949 1/20 0.41
FLT1 P17948 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5572782 0.85 CNR1 (0.46) CNR1AURKBMETPDGFRBCDK8
SCHEMBL14600395 0.84 KMT2A (0.45) CNR1MAPTIDH1MEN1ALDH1A1
SCHEMBL14491899 0.84 KMT2A (0.37) MAOBAURKBMETPDGFRBCDK8
SCHEMBL6405194 0.83 MEN1 (0.47) MAOBCNR1CDK8MAPTHTT
SCHEMBL5569294 0.83 SMN1; SMN2 (0.53) CNR1MAPTPKMHTTGRM5
SCHEMBL6401844 0.83 GRM5 (0.52) MAOBAURKBROCK1NTRK3NTRK2
SCHEMBL6401638 0.72 KDR (0.52) MAOBCNR1GRIK1MAPTHTT
SCHEMBL5335003 0.70 HRH3 (0.46) MAOBMAPTMEN1ALDH1A1KMT2A
SCHEMBL725553 0.68 IDH1 (0.69) CNR1GRIK1MAPTHTTIDH1
SCHEMBL5183009 0.68 TDP2 (0.41) AXLMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050059658-A1 Pyridazinone BAYER AKTIENGESELLSCHAFT (DE) 2005-03-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050059658-A1 Pyridazinone TYMP, TPMT, PDXK MAOB 890/4885CNR1 986/4885AURKB 325/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.